KeyBank National Association’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-4,909
| Closed | -$328K | – | 988 |
|
2018
Q3 | $328K | Sell |
4,909
-486
| -9% | -$32.5K | ﹤0.01% | 876 |
|
2018
Q2 | $254K | Buy |
5,395
+718
| +15% | +$33.8K | ﹤0.01% | 919 |
|
2018
Q1 | $264K | Buy |
4,677
+693
| +17% | +$39.1K | ﹤0.01% | 910 |
|
2017
Q4 | $197K | Buy |
3,984
+416
| +12% | +$20.6K | ﹤0.01% | 992 |
|
2017
Q3 | $271K | Buy |
3,568
+1,048
| +42% | +$79.6K | ﹤0.01% | 950 |
|
2017
Q2 | $237K | Hold |
2,520
| – | – | ﹤0.01% | 1002 |
|
2017
Q1 | $200K | Hold |
2,520
| – | – | ﹤0.01% | 1088 |
|
2016
Q4 | $210K | Buy |
2,520
+162
| +7% | +$13.5K | ﹤0.01% | 1073 |
|
2016
Q3 | $264K | Buy |
2,358
+175
| +8% | +$19.6K | ﹤0.01% | 1017 |
|
2016
Q2 | $242K | Hold |
2,183
| – | – | ﹤0.01% | 996 |
|
2016
Q1 | $228K | Sell |
2,183
-507
| -19% | -$53K | ﹤0.01% | 996 |
|
2015
Q4 | $217K | Buy |
2,690
+751
| +39% | +$60.6K | ﹤0.01% | 1038 |
|
2015
Q3 | $134K | Hold |
1,939
| – | – | ﹤0.01% | 1097 |
|
2015
Q2 | $190K | Hold |
1,939
| – | – | ﹤0.01% | 1149 |
|
2015
Q1 | $190K | Buy |
1,939
+424
| +28% | +$41.5K | ﹤0.01% | 1163 |
|
2014
Q4 | $167K | Buy |
+1,515
| New | +$167K | ﹤0.01% | 1173 |
|